rs1039959
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001394959.1(MARCHF1):c.162+4109C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.453 in 151,814 control chromosomes in the GnomAD database, including 16,081 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.45 ( 16081 hom., cov: 31)
Consequence
MARCHF1
NM_001394959.1 intron
NM_001394959.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.930
Publications
1 publications found
Genes affected
MARCHF1 (HGNC:26077): (membrane associated ring-CH-type finger 1) MARCH1 is a member of the MARCH family of membrane-bound E3 ubiquitin ligases (EC 6.3.2.19). MARCH proteins add ubiquitin (see MIM 191339) to target lysines in substrate proteins, thereby signaling their vesicular transport between membrane compartments. MARCH1 downregulates the surface expression of major histocompatibility complex (MHC) class II molecules (see MIM 142880) and other glycoproteins by directing them to the late endosomal/lysosomal compartment (Bartee et al., 2004 [PubMed 14722266]; Thibodeau et al., 2008 [PubMed 18389477]; De Gassart et al., 2008 [PubMed 18305173]).[supplied by OMIM, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.501 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MARCHF1 | NM_001394959.1 | c.162+4109C>G | intron_variant | Intron 5 of 9 | ENST00000514618.6 | NP_001381888.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.453 AC: 68716AN: 151696Hom.: 16058 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
68716
AN:
151696
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.453 AC: 68769AN: 151814Hom.: 16081 Cov.: 31 AF XY: 0.447 AC XY: 33190AN XY: 74198 show subpopulations
GnomAD4 genome
AF:
AC:
68769
AN:
151814
Hom.:
Cov.:
31
AF XY:
AC XY:
33190
AN XY:
74198
show subpopulations
African (AFR)
AF:
AC:
17557
AN:
41368
American (AMR)
AF:
AC:
6003
AN:
15240
Ashkenazi Jewish (ASJ)
AF:
AC:
1628
AN:
3470
East Asian (EAS)
AF:
AC:
851
AN:
5162
South Asian (SAS)
AF:
AC:
1723
AN:
4812
European-Finnish (FIN)
AF:
AC:
4995
AN:
10530
Middle Eastern (MID)
AF:
AC:
120
AN:
294
European-Non Finnish (NFE)
AF:
AC:
34358
AN:
67924
Other (OTH)
AF:
AC:
983
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1896
3791
5687
7582
9478
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
632
1264
1896
2528
3160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
890
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.